MRI with gadolinium contrast is not associated with increased rates of Parkinson’s disease.
There is no association between gadolinium-based contrast agents (GBCAs) used for MRI scans and Parkinson’s disease, according to a study published in the Journal of the American Medical Association.
Researchers from Canada performed a retrospective study to determine if there was an association between gadolinium exposure and parkinsonism. The study included 246,557 patients with no history of parkinsonism, who had undergone at least one MRI between April 2003 and March 2013. Median age was 73. Patients who had undergone neurosurgery or whose scans were of the brain and spinal cord were not included in the study.
• 99,739 of the 246,557 (40%) received at least one MRI with gadolinium
• 2,244 (3%) received at last four exams with GBCAs[[{"type":"media","view_mode":"media_crop","fid":"50333","attributes":{"alt":"MRI contrast","class":"media-image media-image-right","id":"media_crop_880283631319","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"6134","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 105px; width: 170px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"©sfam photo/Shutterstock.com","typeof":"foaf:Image"}}]]
The results showed that incident parkinsonism developed in the same number of patients in both groups: 1.16% of unexposed patients and 1.17% of those exposed to gadolinium. There was no significant association between gadolinium exposure and parkinsonism.
"This result does not support the hypothesis that gadolinium deposits in the globus pallidi lead to neuronal damage manifesting as parkinsonism,” the authors wrote. “However, reports of other nonspecific symptoms (pain, cognitive changes) after gadolinium exposure require further study.”
New Study Finds Racial Disparities with Pre-Op Breast MRI and Positive Surgical Margin Rates
November 8th 2024In addition to a lower rate of preoperative breast MRI use, emerging research found that Black women with breast cancer who didn’t have a preoperative MRI had a higher positive surgical margin rate than White women with no preoperative MRI.
Can MRI-Based AI Enhance Pre-Op Prediction of Tumor Deposits in Patients with Rectal Cancer?
October 31st 2024For patients with rectal cancer, an emerging nomogram that combines deep learning and clinical factors had greater than 16 percent and 23 percent increases in accuracy and specificity, respectively, for pre-op prediction of tumor deposits in comparison to clinical factors alone.
Artifact Reduction Drives Technology Advances with Updated Version of Echelon Synergy MRI System
October 30th 2024Emerging technologies included with the 10th version of the 1.5T MRI platform include Synergy DLR Clear and Synergy Vision that are geared toward mitigating common challenges with artifacts.